Talas, Zainarah C.
HRN: 22-13-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/25/2022
11/01/2022
IV
17mg
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes